AQP9 is elevated in astrocytic brain tumors [470,471], prostate [422], breast, colorectal, and gastric cancers, and decreased in lung cancer [472] and hepatocellular carcinoma cells [473]. Here, AQP9 is linked to hepatocellular carcinoma.